We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigation of Endothelium in Saphenous Vein Grafts

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01510821
First Posted: January 18, 2012
Last Update Posted: October 1, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Maquet Cardiovascular
Information provided by (Responsible Party):
Vinod Thourani, Emory University
  Purpose
This is a single center prospective study of 30 patients undergoing elective heart bypass surgery (CABG) with at least two vein grafts from the leg (SVG). The purpose of this ex vivo study is to evaluate the function of vein grafts from small tissue samples treated with a pressure syringe and a non-pressure syringe. Syringes are routinely used to flush out the veins in preparation of bypass grafting. It is unknown if different levels of pressure in the syringe affect the vein or damage the vein. Small sections of tissue samples which are normally discarded will be obtained immediately after retrieval from the leg and before grafting to the heart. Tissue samples will be taken to the laboratory for study. There are no clinical endpoints in this study, however, clinical information will be obtained from the Society of Thoracic Surgeons database and will include demographics, risk factors, and perioperative outcomes.

Condition Intervention
Endothelial Function of Saphenous Vein Grafts Other: Use of Maquet Vasoshield Pressure-limiting syringe on SVG Other: Use of non-regulated syringe on SVG

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: A Prospective Trial to Investigate Endothelial Dysfunction in Saphenous Vein Grafts Subjected to the Maquet Vasoshield Pressure Limiting Syringe Versus Non-Regulated Vessel Dilation in Patients Undergoing Coronary Artery Bypass Grafting

Further study details as provided by Vinod Thourani, Emory University:

Primary Outcome Measures:
  • SVG vascular contractility [ Time Frame: Day of surgery ]

Secondary Outcome Measures:
  • Nitric oxide metabolite levels [ Time Frame: Day of surgery ]
  • Major adverse cardiac events [ Time Frame: 6 months and 1 year ]

Enrollment: 30
Study Start Date: November 2011
Study Completion Date: June 2012
Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Maquet Vasoshield Arm
Pressure limiting syringe
Other: Use of Maquet Vasoshield Pressure-limiting syringe on SVG
Use of Maquet Vasoshield Pressure-limiting syringe on SVG
Other Name: Maquet device
Active Comparator: Non-regulated Arm
standard non-regulated syringe
Other: Use of non-regulated syringe on SVG
Use of non-regulated syringe on SVG
Other Name: standard syringe

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patients undergoing elective coronary artery bypass graft surgery requiring at least 2 saphenous vein grafts

Exclusion Criteria:

  • patients undergoing any concomitant surgical procedures
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01510821


Locations
United States, Georgia
Cardiothoracic Surgery Research Laboratory
Atlanta, Georgia, United States, 30308
Emory University Hospital Midtown
Atlanta, Georgia, United States, 30308
Sponsors and Collaborators
Emory University
Maquet Cardiovascular
Investigators
Principal Investigator: Vinod Thourani, MD Emory University
  More Information

Responsible Party: Vinod Thourani, Associate Professor of Surgery, Emory University
ClinicalTrials.gov Identifier: NCT01510821     History of Changes
Other Study ID Numbers: IRB00049331
First Submitted: November 2, 2011
First Posted: January 18, 2012
Last Update Posted: October 1, 2013
Last Verified: September 2013

Keywords provided by Vinod Thourani, Emory University:
endoscopic vein harvest
saphenous vein graft
endothelial function